# JUR-003 in Adult Patients With Metastatic Prostate Cancer

Source: https://onco.cc/trials/nct07824349/  
OnCo record `nct07824349` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of JUR-003 run by Juri Biosciences, Inc., now recruiting.

## Summary

JUR-003 in Adult Patients With Metastatic Prostate Cancer is a phase 1 interventional study registered as NCT07824349 by Juri Biosciences, Inc., with 210 participants planned, started 2026-09. Conditions recorded: Metastatic Castration Resistant Prostate Cancer, Oligometastatic Prostate Cancer (OMPC) and Metastatic Hormone Sensitive Prostate Cancer. Interventions recorded: JUR-003.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07824349
- Phase: 1
- Setting: A Phase 1a/1b Open Label, Multicenter, Dose Escalation and Dose Expansion Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Activity of JUR-003 in Adult Patients With Metastatic Prostate Cancer
- Sponsor: Juri Biosciences, Inc.
- Enrolled: 210

## Sources

- ClinicalTrials.gov NCT07824349: https://clinicaltrials.gov/study/NCT07824349

## Connected records

- cancers: [Metastatic castration-resistant prostate cancer](https://onco.cc/cancers/prostate-mcrpc/), [Metastatic hormone-sensitive prostate cancer](https://onco.cc/cancers/prostate-mhspc/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- drugs: [JUR-003](https://onco.cc/drugs/jur-003/)
- companies: [Juri Biosciences](https://onco.cc/companies/juri-biosciences/)

---
JSON: https://onco.cc/api/v1/entities/nct07824349.json